Your guide to the pharmaceutical world Volume 6 Issue 2TemperaturecontrolCold factsContraceptionFinding a pill for menProcessingApplied automationPharmaBUSINESS INTERNATIONALThe total packageFrom development to dispensingThe total packageFrom development to dispensingTemperaturecontrolCold factsContraceptionFinding a pill for menProcessingApplied automationwww.pbiforum.net01_Layout 1 11/04/2018 10:34 Page 1THE UK’S LEADING PRODUCTION LINE EVENTSee the latest processing and packaging machinery in action, network with industry peers and gain valuable insight at our must attend seminars.ORGANISED BY25-27 SEPT 2018 NEC, BIRMINGHAM FREETO ATTENDREGISTER NOW!ppmashow.co.ukPROCESSING & PACKAGING MACHINERYMATERIALS I ROBOTS I INDUSTRIAL VISION NEC, BIRMI25-27 GHAMNNEC, BIRMI 2018EPTS25-27 ROT W!NOEGISTERRTTEND AOREEF and packaging machinerySee the latest PRODUCTION LINE EVENTTHE UK and packaging machineryocessing prSee the latest PRODUCTION LINE EVENT’S LEADING THE UK and packaging machineryocessing PRODUCTION LINE EVENT’S LEADING at our must attend seminars.peers and gain valuable insight in action, network with industry and packaging machinery at our must attend seminars.peers and gain valuable insight in action, network with industry and packaging machinery at our must attend seminars.peers and gain valuable insight in action, network with industry and packaging machinery ORIRIALS ETAMG & NSSICEPROppmashow DUSTRIAL VISIOINITS OBONEHICAMG NKAGICAPG & .co.ukppmashow NDUSTRIAL VISIOYRNE YORGANISED B 02_Layout 1 11/04/2018 10:34 Page 1@pbiforumwww.pbiforum.netcompany/pbiforumContentsVolume 6 Issue 2News4(A@0C94CA?C3@ABC+<A:CA:BC8@AB;AC<>39;A=0C943@AB;C2=?7A:BC58?/@8C4:@=7@6B9A<6@8CAB6:>?8?50C<>39;A=0Zika Exposé8 :@=7@C9;<>B;;C>AB=>@A<?>@8CB48?=B;C;?7BC?2CA:B7?;AC4=?7<;<>5C<>>?.@A<?>;C@>3C+:@ACA:BC29A9=BC:?83;2?=CA=B@A7B>AProcessing12 ;C+<A:C@87?;ACB.B=0C?A:B=C<>39;A=0C=B8<@>AC?>C6?748B7@>92@6A9=<>5,C@9A?7@AB3CAB6:>?8?50C<;C:@.<>5C@A=@>;2?=7@A<.BCB22B6ATemperature Control16 %B74B=@A9=BC6?>A=?8C<;C@>C<>6=B@;<>580CB4B>;<.BC4@=A?2CA:BC4:@=7@C;94480C6:@<>,C/9AC>?C8B;;C>B6B;;@=0C2?=A:@AContraception20 (6<B>A<;A;C=B7@<>C6?>2<3B>ACA:@AC@C;@2B,CB22B6A<.BC@>3=B.B=;</8BC7@8BC6?>A=@6B4A<.BC+<88CB.B>A9@880C/B6?7B=B@8<A0Compliance24 B+C4=?396A;C79;AC7BBAC=B598@A<?>;C@>3C;A@>3@=3;,+:<6:C6@>C4=?.BCA:BC/<55B;AC:9=38BC2?=C7@>0C>B+3=95;C8??-<>5CA?CB>AB=CA:BC7@=-BAMergers & Acquisitions28 :@=7@C9;<>B;;C>AB=>@A<?>@8C6:B6-;C<>C+<A:CA:B58?/@8C C7@=-BA,C:<5:8<5:A<>5C;?7BC?2CA:BC/<55B=3B@8;CA?C:@.BCA@-B>C48@6BC?.B=CA:BC8@;AC7?>A:Cold Chain32A;C<>CA:BC<>39;A=0;C/B;AC<>AB=B;ACA?C7@<>A@<>C6?836:@<>C<>AB5=<A0CA:=?95:?9ACA:BCB>A<=BC;94480C6:@<>,/?A:CA?C4=B;B=.BC4=?396AC<>AB5=<A0C@>3C@8;?CA?;@2B59@=3CA:BC4@A<B>A;C3B4B>3B>AC94?>C<AVitafoods35%@-<>5C48@6BC/BA+BB>C''C@0C&' C<>C@8B4?,B>B.@,C<A@2??3;C"9=?4BC?22B=;CA:BC7?;AC6?748BAB7@=-BAC?.B=.<B+C?2C>9A=@6B9A<6@8C<>5=B3<B>A;C<>CA:B+?=83Events36BC5<.BC@C=9>3?+>C?2C4:@=7@CB.B>A;C:@44B><>5@=?9>3CA:BC+?=838162432Group Editor:(AB.BC<;:B=C*;12<;:B=#/875=?9416?19-)CCCCEditor:<6:@B8C<;:B=C*712<;:B=#/875=?9416?19-)CCJournalist:?7<><6C9A:/B=A*3169A:/B=A#/875=?9416?19-)Sales Director: >5<BC??4B=C*@16??4B=#/875=?9416?19-)Sales Manager:(@7C%=?AAC*;1A=?AA#/875=?9416?19-)Sales:<6-0C9>AC*.1:9>A#/875=?9416?19-)%B8C$$C*&)C'$C!'&!&CCCCCAccounts & Subscriptions: >5B8@C(:@=7@>*@1;:@=7@>#/875=?9416?19-)Design & Production:@=0C?=5B>;B>,@=-C@;;?>,*;A93<?#/875=?9416?19-)Editorial:%B8C$$C*&)C'$C!'&!&,C@C$$C*&)C'$C!'&!'Part of BLMGroup: =7;A=?>5C?9;B,C =7;A=?>5C(A=BBA,=<7;/0,CC"C<>6;C!'C "C">58@>3All rights reserved. No part of this publication may be reproduced,transmitted, photocopied, recorded or otherwise without expresspermission of the copyright holder, for which application should beaddressed first to the publisher. While every reasonable care istaken, neither the publisher nor its participating agents acceptliability for loss or damage to prints, colour transparencies,negatives or other material of whatever nature submitted to thispublication. The views expressed in this publication are notnecessarily the views of those held by the publisher.This magazine is now fully recyclable. By recycling magazines, youcan help reduce waste and add to the 5.5 million tonnes of paperalready recycled by the UK paper industry each year. Before yourecycle your magazine, please ensure you remove all plasticwrapping, free gifts and samples. "C%CC(%%"(%CC"(C"(( C03_Layout 1 11/04/2018 10:35 Page 14Pharma Business International www.pbiforum.netLatest newsResearchers develop new way to fightsuperbugs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ovartis works towardsvirtual clinical trials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amper evident labelling from Newman Labelling meet FalsifiedMedicines DirectiveLKDOKDNOMFGL>LNCONCLELJNGO.LHNEKL<NO, /*OEIALJ?OLJOKIO>IHENO;=N;H@MH=O, 9O#N:AMJO-M;NFFLJ?O0=GKNAGOLGOBHI<LCLJ?OE@GKIANHGO:LKDOK:IFM;NFFLJ?OGIF@KLIJGO'OKDNO53/%(,OMJCO53/(,O'OKIONJG@HNOEIABFLMJEN83DNOMFGL>LNCONCLELJNGO.LHNEKL<NOHN@LHNGOK:IOAMJCMKIH=OGM>NK=O>NMK@HNGOKDMKO:LFFNJM;FNOANCLELJNGOKIO;NO<NHL>LNCOMJCOM@KDNJKLEMKNCOMFIJ?OKDNOG@BBF=OEDMLJOKMABNHN<LCNJKO>NMK@HNGOIJOKDNOEMHKIJOMJCOMO@JL@NOLCNJKL>LNHO".OCMKMOAMKHL$OEICNOMJCD@AMJOHNMCM;FNOLJ>IHAMKLIJ!OIJOKDNOEMHKIJ8#N:AMJO53/%(,OMJCO53/(,OM@KIAMKLEOKMABNHON<LCNJKOFM;NFFNHGONJM;FNE@GKIANHGOKIOANNKOKDNGNOJN:OHN?@FMKLIJG9O:DLFGKOMFGIOBHI<LCLJ?ODL?DOFN<NFGOI>>FN$L;LFLK=9O@MFLK=OMJCOHNFLM;LFLK=8O.NGL?JNCOKIOMBBF=OMOHMJ?NOI>OGNF>7MCDNGL<NOKMABNH7N<LCNJK9OMJKL7EI@JKNH>NLKOMJCODIFI?HMAOFM;NFG9OMOGLJ?FNOAMEDLJNOEMJODMJCFNOMO:LCNHMJ?NOI>OEMHKIJOK=BNGOMJCOGL NGO:LKDI@KOKDNOJNNCO>IHOEDMJ?NOBMHKG8OO0BNEL>LEMFF=OCNGL?JNCO>IHODNMFKDEMHNOMBBFLEMKLIJG9OKDNO53/%(,OMJCO53/(,ODM<NMOGKMLJFNGGOGKNNF2OEIJGKH@EKLIJOMJCOMHNOM<MLFM;FNO:LKDO>@FFOMFLCMKLIJ.IE@ANJKMKLIJO2ME6M?N8OO© Shutterstock / Photon photo.HOMKDMHLJMO+LEDKNH85HNCLKO+@GGNFFOLFFMHC93DNO*JL<NHGLK=OI>4CNFMLCN04-07_Layout 1 11/04/2018 10:36 Page 1Prevail raises $75m to advancedParkinson’s gene therapies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harma Business International 5www.pbiforum.netLatest newsOncology collaboration sees Eisai and Merck develop Lenvima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ulti-million funding grant forpromising anti-cancer drug4OBMLHOI>OBHI>NGGIHGO>HIAOKDNO*JL<NHGLK=OI>O4@E6FMJCOMHNO;NDLJCOMJMJKL7EMJENHOCH@?OKDMKODMGOHNENJKF=OGEIIBNCOMOA@FKL7ALFFLIJOCIFFMH>@JCLJ?O?HMJKOLJO/@HIBN84GGIELMKNO2HI>NGGIHGON>>O0AMLFFOMJCO4CMAO2MKKNHGIJOI>OKDN*JL<NHGLK=1GO4@E6FMJCO5MJENHO0IELNK=O+NGNMHEDO5NJKHNO"450+5!CNGL?JNCOKDNOEDNAIKDNHMB=OCH@?O527(,OI<NHOMOKDHNNO=NMHOBNHLIC8#I:O&NF?L@A7;MGNCO5IJ<NHKO2DMHAMEN@KLEMFGODMGOGNE@HNCO%OALFFLIJKIOCN<NFIBOKDNOMJKL7EMJENHOCH@?8@JCGO:LFFO;NO@GNCOKIOBHNBMHNOMJCOEIJC@EKOLJLKLMFOEFLJLEMFOGK@CLNGKDMKOEI@FCOGKMHKOMGONMHF=OMGOJN$KO=NMH8527(,OLGOMOEDNAIKDNHMB=OCH@?OKDMKOLGOM;FNOKIOKMH?NKOEMJENHOENFFGKDMKOMHNOI$=?NJ7CNBHL<NCO:DLFGKOGBMHLJ?OJIHAMFOKLGG@NGO'OLABHI<LJ?OKDNMEKL<LK=9OGBNEL>LELK=OMJCOGM>NK=OHNFMKL<NOKIOIFCNHOEDNAIKDNHMB=OCH@?G83DNGNOBHICH@?GOMHNOLJMEKL<NO;=OKDNAGNF<NG9O;@KOKHMJG>IHAOLJKIBIKNJKOMJKL7EMJENHOM?NJKGO:DNJONJKNHLJ?OK@AI@HG9OGMLCO4GGIELMKN2HI>NGGIHO2MKKNHGIJ8© Shutterstock / Crevis© Shutterstock / Ocskay Mark © Shutterstock / tarapong srichaiyos 04-07_Layout 1 11/04/2018 10:36 Page 2BCI Pharma to accelerate researchprojects with €1.9m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harma Business International www.pbiforum.netLatest newsNew tool developed forimprinting biochips%.OBHLJKLJ?ODMGODNFBNCOMOKNMAOI>OHNGNMHEDNHGOMKOKDNO4C<MJENC0ELNJENO+NGNMHEDO5NJKHNO"40+5!OMKOKDNOHMC@MKNO5NJKHNOI>OKDNO5LK=*JL<NHGLK=OI>O#N:OIH6OCN<NFIBOMOJN:9OBIKNJKLMFF=OAIHNON>>LELNJKOMJCEIGK7N>>NEKL<NOANKDICO>IHOBHNBMHLJ?O;LIEDLBG8&LIEDLBGOMHNO@GNCOKIOGEHNNJO>IHOMJCOMJMF=GNO;LIFI?LEMFOEDMJ?NGMGGIELMKNCO:LKDOCLGNMGNOCN<NFIBANJK9O;LIKNHHIHLGAOM?NJKG9OMJCOIKDNHMHNMGOI>OHNGNMHEDOKDMKOLJ<IF<NO;LIFI?LEMFOEIABIJNJKG8)JOMOBMBNHOB@;FLGDNCOLJO9OHNGNMHEDNHGO:LKDOKDNO40+51G#MJIGELNJENO)JLKLMKL<NOCNKMLFODI:OKDN=ODM<NOEIA;LJNCOALEHI>F@LCLEKNEDJL@NGO:LKDO;NMA7BNJOFLKDI?HMBD=OMJCOBDIKIEDNALEMFOG@H>MENHNMEKLIJGOKIOCN<LGNOMOJN:O;LIEDLBOBHLJKLJ?OKNEDJL@N83DNOANKDICOLJ<IF<NGON$BIGLJ?OMO;LIEDLB1GOG@H>MENOKIOGBNEL>LEIH?MJLEOHNM?NJKGOMJCOKDNJO@GLJ?OMOKL?DKF=O>IE@GNCO;NMAOI>OFL?DKOKIMCDNHNOKDNOLAAI;LFLGNCOHNM?NJKGOKIOKDNOEDLB1GOG@H>MEN83DNOHNG@FKOLGOMO;LIEDLBOKDMKOEMJOMEEIAAICMKNOAIHNOBHI;NGOKDMJOLGOMEDLN<M;FNO:LKDOE@HHNJKEIAANHELMFOBFMK>IHAG8British biotech to manufacturenovel medicines for microbiome&HLKLGDO;LIKNEDO;@GLJNGG9O2&-9ODMGO?MLJNCO?HMJKO>@JCLJ?O>HIA)JJI<MKNO*OKIOLJ<NGKL?MKNOKDNOAMJ@>MEK@HNOI>OMOJN:OEFMGGOI>OANCLELJNG83DNGNOJN:OKHNMKANJKGO:LFFOKMH?NKOMOHMJ?NOI>OEFLJLEMFOEIJCLKLIJGOKDHI@?DLJKNHMEKLIJO:LKDOKDNOD@AMJOALEHI;LIAN83DNOJI<NFOMJCODL?DF=OLJJI<MKL<NOMBBHIMEDOLGOKIO@GNOGBIHNGOCNHL<NC>HIAOMJMNHI;LEO;MEKNHLMO"5FIGKHLCLM!OKDMKOMHNOJMK@HMFF=O>I@JCOLJOI@HOFMH?NLJKNGKLJNGOKIOCNFL<NHOKMH?NKNCOMJKL7LJ>FMAAMKIH=OKDNHMBN@KLEG8&MEKNHLMFOGBIHNGOMHNOHNGLGKMJKOKIOMELC9OGIO:DNJOLJ?NGKNCOLJOMOKM;FNKOIHEMBG@FNOKDN=OMHNOM;FNOKIOBMGGOFMH?NF=O@JGEMKDNCOKDHI@?DOKDNOGKIAMED;N>IHNO?NHALJMKLJ?OMJCOHNFNMGLJ?OKDNOMJKL7LJ>FMAAMKIH=O;LI7MEKL<NG"BM=FIMC!OKIO:DNHNOLKOLGOJNNCNCOLJOKDNOEIFIJ9OKIOKHNMKOEDHIJLEOMJCCN;LFLKMKLJ?OLJ>FMAAMKIH=OEIJCLKLIJG9OG@EDOMGO*FENHMKL<NO5IFLKLGOMJC5HIDJ1GO.LGNMGN8© Shutterstock / Anatomy Insider© Shutterstock / Marian Weyo © Shutterstock / science photo04-07_Layout 1 11/04/2018 10:36 Page 3 Atomwise raises $45m tobecome pharma’spreferred AI partner4KIA:LGNODMGOHMLGNCO(OALFFLIJOLJO0NHLNG4O>@JCLJ?OLJOLKGOIJ?ILJ?O;LCOKIO;NEIANOKDNBHN>NHHNCOMHKL>LELMFOLJKNFFL?NJENO"4)!OBMHKJNHO>IHKDNO?FI;MFOBDMHAMEN@KLEMFOLJC@GKH=8O3DNI<NHG@;GEHL;NCOHI@JCO;HLJ?GO4KIA:LGN1GKIKMFOEMBLKMFOHMLGNCOKIOAIHNOKDMJO( OALFFLIJ83DNOEIABMJ=OGMLCOKDNO>@JCLJ?OAMH6GOKDNE@FALJMKLIJOI>OK:IO=NMHGOI>O@JBHNENCNJKNC;@GLJNGGO?HI:KD8O4KIA:LGNODMGOGKH@E6BMHKJNHGDLBGO:LKDO>I@HOI>OKDNOKIB7KNJO*0OBDMHAMOEIABMJLNG9A@FKLBFNO;LIKNEDO>LHAGOMJCOI<NHO>IHK=OAMIHOHNGNMHEDO@JL<NHGLKLNG8-L6NOGI>K:MHNO@GNCOKIOCNGL?JOMLHBFMJNGOMJCOEIAB@KNHOEDLBGOLJGLA@FMKLIJ9O4KIA:LGNOEMJODNFBOAM6NOBHNCLEKLIJGOM;I@KOJN:BIKNJKLMFOANCLELJNGO;N>IHNOKDN=OMHNOAMCN9OHNC@ELJ?OKDNOJNNCO>IHEIGKF=OMJCOKLAN7EIJG@ALJ?OBD=GLEMFOG=JKDNGLGOMJCOKNGKLJ?8)KGO?HI@JC;HNM6LJ?O4KIA#NKOCH@?OHNGNMHEDOKNEDJIFI?=OFNMHJGFL6NOMOD@AMJOEDNALGK9O@GLJ?OBI:NH>@FOCNNBOFNMHJLJ?OMF?IHLKDAGMJCONFMGKLEOG@BNHEIAB@KNHOBFMK>IHAGOKIOMJMF=GNOALFFLIJGOI>BIKNJKLMFOANCLELJNGONMEDOCM=8Pharma Business International 7www.pbiforum.netLatest newsDHL and Accenture unlock the power ofblockchain in logistics to cut counterfeitdrugs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© atomwise© Shutterstock / NicoElNino04-07_Layout 1 11/04/2018 10:36 Page 4ZIKA EXPOSÉ8Pharma Business International www.pbiforum.net(?+AC8A=C:B6B>@B7C?@=B93C?>C@8BC45.9?::<>=:?<5=>B==C@8B=BC9A=@C3B-C0BA;=C-?@86A"<;C<5@.;BA+=CA:;<==C!<5@8C)6B;?:AA>7C4A;@=C<3C)3;?:A,C @C-A=C<33?:?A9907B:9A;B7CAC45.9?:C8BA9@8CB6B;2B>:0C.0@8BC<;97CBA9@8C;2A>?=A@?<>C?>C$',(?+AC?=C=4;BA7C4;B7<6?>A>@90C.0C@8B)B7B=C6<=5?@</C-8?:8C@;A>=6?@=?>3B:@?<>C3;<6C4B;=<>C@<C4B;=<>C@8;<528.9<<7C:<>@A:@,C5@/C5>9?+BC%B>25B/C(?+A:A>CA9=<C.BC=4;BA7C=B5A990,C*8BC1?;5=C:A>C6A>?3B=@C?>C=064@<6==5:8CA=C6?97C3B1B;/C=+?>C;A=8/C6A9A?=BCA>7"<?>@C4A?>/CA6<>2C<@8B;=/C.5@C:A>C8A1B65:8C6<;BC=B;?<5=CB33B:@=C-?@8C4;B2>A>@-<6B>,C*8BC=:?B>@?3?:CB1?7B>:BC@8A@C(?+A:A5=B=C6?:;<:B48A90CA>7C5?99A?>&A;;=0>7;<6BC?=C:<64B99?>2/C-8?9BC@8BC9A@B=@;B=BA;:8C?=CB49<;?>2C?@=C9?>+=C@<C<@8B;>B5;<9<2?:A9C:<649?:A@?<>=,C1B;C''/''':A=B=C<3C(?+AC1?;5=C?>3B:@?<>C8A1BC.BB>;B4<;@B7C?>C@8BC)6B;?:A=C=?>:BC$',!533?:BC?@C@<C=A0/CAC;<.5=@@;BA@6B>@CA>71A::?>BC4;<2;A66BC?=C4A;A6<5>@,CC*8BC(?+AC;B=BA;:8CA>7C7B1B9<46B>@=4A:B/CB=4B:?A990C?>C@8BC>?@B7C!@A@B=/8A=C.BB>C@?;B9B==90C-<;+?>2CA-A0C@<;B6B70C@8?=,C*8?=C0BA;/C@8BC <<7CA>7%;52C)76?>?=@;A@?<>C %)C3A=@&@;A:+B7*A+B7A#=C!C7B=?2>A@?<>C3<;C?@=C-8<9B(?+AC1?;5=C1A::?>BC:A>7?7A@B/C*)&$,*8BCA?6C<3C@8BC7B=?2>A@?<>C?=C@<CB4B7?@B@8BC7B1B9<46B>@CA>7C;B1?B-C<3C7;52=A>7C@;BA@6B>@=C@8A@C3?99CA>C5>6B@C6B7?:A9>BB7,C*8A@C@8BC %)C?=C2;A>@?>2C=5:87B=?2>A@?<>=C@<C(?+AC@;BA@6B>@=C?=C@B99?>2/A>7C-?@8C><C1A::?>BC<;C6B7?:?>B:5;;B>@90CA1A?9A.9BC@<C(?+A/C4<@B>@?A9@;BA@6B>@=C=5:8CA=C@8B=BCA;BC:;?@?:A9,C*8<528C@8BC6B7?:?>B=CA>7C7;52=@8B6=B91B=CA;BC5>7<5.@B790C?64<;@A>@/@8BC-A0C?>C-8?:8@8B0#;BCA76?>?=@B;B7:A>CA9=<C8A1BCAC=?2>?3?:A>@?64A:@,C)C=@570C45.9?=8B7C?>C ;B4<;@B7C@8A@C@8BZika, dengue and malariabelong to a group ofmosquito-borne diseases whichmakes preventative measuresdifficult at best. Here, PharmaBusiness Internationalexplores some of the mostpromising innovations foreach respective disease andwhat the future holds fortreatment. © Shutterstock / nechaevkonIn need of vaccine08-11_Layout 1 11/04/2018 10:40 Page 1Pharma Business International 9www.pbiforum.netZIKA EXPOSÉ vaccine10 Á7B9?1B;0C<3CAC(?+AC1?;5=C1A::?>BC1?A8A;6AB@#=C>BB79B9B==C?>"B:@<;7B6<>=@;A@B7CAC8?28B;C?665>BC;B=4<>=B@<C@8A@C<3C>BB79BCA>7C=0;?>2B,C59@?49BC=@57?B=C8A1BC=8<->C@8A@>BB79B&3;BBC?>"B:@<;=CA526B>@C%)1A::?>BC;B=4<>=B/C4<==?.90C.0C?>:;BA=B77?=4B;=?<>C<3C?>"B:@A@BC<;C@8;<528C@?==5B7?=;54@?<>C@8A@C?>:;BA=B=C?665><2B>?:?@0,''C4B;C:B>@C<3C4A;@?:?4A>@=C-8<;B:B?1B7C@8BC(?+AC1?;5=C1A::?>BC.0>BB79B&3;BBC?>"B:@?<>C?>C=49?@C7<=B=8A7C7B@B:@A.9BA>@?.<70C;B=4<>=B=/C4;<75:B7>B5@;A9?=?>2CA>@?.<7?B=/CA>7C8A7C@8B8?28B=@C*&:B99C;B=4<>=B=,)C1?A.9BC(?+AC1A::?>BC?=CB4B:@B7C@<C.BA1A?9A.9BC?>CAC6A@@B;C<3C0BA;=/C.5@C@8BB33B:@?1B>B==C<3C@8?=C1A::?>BC?>4;B1B>@?>2C?@=CB33B:@=C7B4B>7=C><@C"5=@C<>?@=CB33?:A:0/C.5@CA9=<C<>C7B6<2;A48?:CA>73B;@?9?@0C4A@@B;>=/C9<:A9C(?+ACA@@A:+C;A@B=A>7/C<3C:<5;=B/C<>C@8BC4;<4<;@?<>C<3C@8B4<459A@?<>C=@?99CA@C;?=+C-8B>CAC4;<=4B:@?1B1A::?>BC.B:<6B=CA1A?9A.9B,C<-/C;B=BA;:8B;=C3;<6CA9BC!:8<<9C<35.9?:CBA9@8C-;?@?>2C?>C 8A1BC7B1B9<4B7CAC:<645@B;6<7B9C?>C<;7B;C@<C5A>@?30C@8BCB33B:@C<3AC(?+AC1A::?>A@?<>C=@;A@B20C@8A@4;?<;?@?=B7C-<6B>CA2B7C>?>BC@<C3<;@0&>?>B/C3<99<-?>2C.0C6B>C<3C@8BC=A6BCA2B,*8BC;B=BA;:8C3<5>7C@8A@CAC1A::?>BC-A=A.<5@CC4B;C:B>@CB33B:@?1BCA>7C:<1B;B7A.<5@C'C4B;C:B>@C<3C-<6B>CA=C-B99CA=08-11_Layout 1 11/04/2018 10:40 Page 2Next >